ABVX logo

Abivax SA American Depositary Shares (ABVX)

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
ABVX
ISIN Code
US00370M1036
Currency
US Dollar (USD)
IPO Date
2023-10-20

Contact Information

Company Address
7-11 Boulevard Haussmann, Paris, France, 75009
Contact Phone
33 1 53 83 09 63
Company Website
https://www.abivax.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
-44.65%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99